This page is structured for clarity and comparison
For patients with confirmed pernicious anaemia or malabsorption disorders, injectable therapy remains the recommended first-line treatment according to NICE CKS guidance, as oral supplementationregardless of dosecannot reliably correct deficiency in these circumstances
2026 Safety Update: What Patients Should Know About BPC-157 BPC-157 continues to receive attention for recovery, tendon support, gut health, and injury-related concerns, but patients should understand the safety and regulatory picture before considering it
Association of vitamin B status with risk of dementia in cohort studies: a systematic review and meta-analysis
Retatrutide is an investigational compound that has not been approved for human consumption or therapeutic use by any regulatory authority
Another study shows that the low side of vitamin B12 can lead to poor memory performance